|
US8992984B1
(en)
|
2009-10-21 |
2015-03-31 |
Stc.Unm |
Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
AU2012249474A1
(en)
|
2011-04-28 |
2013-11-07 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
|
AU2012284147A1
(en)
|
2011-07-19 |
2014-02-27 |
Stc. Unm |
Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9273305B1
(en)
|
2012-04-25 |
2016-03-01 |
Sandia Corporation |
Cell-based composite materials with programmed structures and functions
|
|
CN113842362A
(zh)
|
2012-11-14 |
2021-12-28 |
格雷斯公司 |
含有生物活性材料与无序无机氧化物的组合物
|
|
SI3150616T1
(sl)
|
2012-11-16 |
2017-08-31 |
University College Cardiff Consultants Limited |
Mešanica rp/sp gemcitabin-(fenil-(benziloksi-l-alaninil))-fosfata
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
EP4378461A3
(en)
|
2013-03-05 |
2024-09-11 |
The Regents of University of California |
Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
|
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2014201276A1
(en)
*
|
2013-06-12 |
2014-12-18 |
The Methodist Hospital |
Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents
|
|
WO2015013352A2
(en)
*
|
2013-07-25 |
2015-01-29 |
Patel Hasmukh B |
Nucleoside phosphoramidates and phosphoramidites
|
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015042279A1
(en)
*
|
2013-09-18 |
2015-03-26 |
Stc. Unm |
Torroidal mesoporous silica nanoparticles (tmsnps) and related protocells
|
|
EP3046547A4
(en)
*
|
2013-09-18 |
2017-05-24 |
Stc.Unm |
Core and surface modification of mesoporous silica nanoparticles to achieve cell specific targeting in vivo
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015066717A1
(en)
*
|
2013-11-04 |
2015-05-07 |
BioPharmX, Inc. |
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
|
|
CA2943109A1
(en)
*
|
2014-01-17 |
2015-07-23 |
Nariyoshi Shinomiya |
Molecule associated with onset of gout, and method and kit for evaluating diathesis of uric acid-related disease and inflammation-related diseases, and inspection object and drug
|
|
US20170204152A1
(en)
|
2014-07-16 |
2017-07-20 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
US11786469B2
(en)
|
2014-07-22 |
2023-10-17 |
Cheolhee WON |
Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasome
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
US20160090603A1
(en)
*
|
2014-09-30 |
2016-03-31 |
Sandia Corporation |
Delivery platforms for the domestication of algae and plants
|
|
KR102601922B1
(ko)
|
2014-11-05 |
2023-11-15 |
셀렉타 바이오사이언시즈, 인크. |
안정한 과-포화 상태로 라파마이신을 포함하는 합성 나노담체와 관련된 방법 및 조성물
|
|
WO2016145031A1
(en)
*
|
2015-03-09 |
2016-09-15 |
Stc.Unm |
Cd 47 containing porous nanoparticle supported lipid bilayers (protocells)
|
|
AU2016252393A1
(en)
*
|
2015-04-24 |
2017-11-09 |
Colgate-Palmolive Company |
Porous protein particles as carriers for actives
|
|
CN114533898B
(zh)
*
|
2015-07-09 |
2025-07-01 |
加利福尼亚大学董事会 |
融合脂质体包被的多孔硅纳米颗粒
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
US10624949B1
(en)
|
2015-07-27 |
2020-04-21 |
National Technology & Engineering Solutions Of Sandia, Llc |
Methods for treating diseases related to the wnt pathway
|
|
JP6948313B6
(ja)
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
KR20180063885A
(ko)
*
|
2015-09-24 |
2018-06-12 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
전이 감소를 위한 방법 및 조성물
|
|
CN105174211B
(zh)
*
|
2015-10-12 |
2017-02-01 |
海南大学 |
一种具有表面增强拉曼活性银基复合纳米材料的制备方法及其所得产品和应用
|
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
|
EP4011451A1
(en)
|
2015-10-22 |
2022-06-15 |
ModernaTX, Inc. |
Metapneumovirus mrna vaccines
|
|
WO2017070601A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
AU2016342376A1
(en)
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Sexually transmitted disease vaccines
|
|
JP6667896B2
(ja)
*
|
2015-11-06 |
2020-03-18 |
国立研究開発法人産業技術総合研究所 |
リボ核酸固定化担体及びそれを用いたリボ核酸の分離回収方法
|
|
PL3386484T3
(pl)
|
2015-12-10 |
2022-07-25 |
Modernatx, Inc. |
Kompozycje i sposoby dostarczania środków terapeutycznych
|
|
LT3394030T
(lt)
|
2015-12-22 |
2022-04-11 |
Modernatx, Inc. |
Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
|
|
PL3394093T3
(pl)
|
2015-12-23 |
2022-05-16 |
Modernatx, Inc. |
Metody stosowania polinukleotydów kodujących ligand ox40
|
|
WO2017120504A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Durfee Paul N |
Osteotropic nanoparticles for prevention or treatment of bone metastases
|
|
EP4218739A3
(en)
*
|
2016-01-08 |
2023-08-09 |
The Regents of The University of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
|
MA43587A
(fr)
|
2016-01-10 |
2018-11-14 |
Modernatx Inc |
Arnm thérapeutiques codant pour des anticorps anti-ctla-4
|
|
WO2017181115A1
(en)
*
|
2016-04-14 |
2017-10-19 |
Spinnaker Biosciences, Inc. |
Porous silicon materials comprising a metal silicate for delivery of therapeutic agents
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
CN109789092A
(zh)
*
|
2016-07-13 |
2019-05-21 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
EP3269444A1
(en)
*
|
2016-07-14 |
2018-01-17 |
Base4 Innovation Ltd |
Method of identifying droplets in a stack and an associated sequencer
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
MA46766A
(fr)
|
2016-11-11 |
2019-09-18 |
Modernatx Inc |
Vaccin antigrippal
|
|
WO2018107088A2
(en)
|
2016-12-08 |
2018-06-14 |
Modernatx, Inc. |
Respiratory virus nucleic acid vaccines
|
|
LU100023B1
(en)
|
2017-01-20 |
2018-07-30 |
Luxembourg Inst Science & Tech List |
Nanocapsules and method for manufacturing thereof
|
|
CN106822916B
(zh)
*
|
2017-01-25 |
2020-02-28 |
浙江大学 |
一种pH敏感的纳米化Bcl-2选择性抑制剂的制备方法及产物和应用
|
|
CN109152830B
(zh)
|
2017-01-27 |
2023-11-03 |
卫理公会医院 |
用于免疫疗法的核/壳结构平台
|
|
CA3052561C
(en)
|
2017-02-06 |
2023-02-14 |
Lemonex Inc. |
Physiologically active substance carrier
|
|
US11344629B2
(en)
|
2017-03-01 |
2022-05-31 |
Charles Jeffrey Brinker |
Active targeting of cells by monosized protocells
|
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
WO2018170256A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
WO2018170245A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
EP4186888B1
(en)
|
2017-03-15 |
2025-11-26 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
EP3595713A4
(en)
|
2017-03-15 |
2021-01-13 |
ModernaTX, Inc. |
RESPIRATORY SYNCYTIAL VIRUS Vaccine
|
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
US11007516B1
(en)
|
2017-06-19 |
2021-05-18 |
National Technology & Engineering Solutions Of Sandia, Llc |
Tunable metal-organic framework compositions and methods thereof
|
|
CN116898870A
(zh)
*
|
2017-07-28 |
2023-10-20 |
雷莫内克斯生物制药有限公司 |
用于预防或治疗肝癌的药物组合物
|
|
EP3675817A1
(en)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
KR102152348B1
(ko)
|
2017-09-05 |
2020-09-08 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
WO2019050283A1
(ko)
*
|
2017-09-05 |
2019-03-14 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
WO2019055807A1
(en)
|
2017-09-14 |
2019-03-21 |
Modernatx, Inc. |
RNA VACCINES AGAINST ZIKA VIRUS
|
|
US10933027B1
(en)
*
|
2017-09-25 |
2021-03-02 |
National Technology & Engineering Solutions Of Sandia, Llc |
Expanded pore particles and delivery methods thereof
|
|
CN107952076A
(zh)
*
|
2017-11-07 |
2018-04-24 |
徐州医科大学 |
一种多囊脂质体/多孔碳纳米复合物、制备方法及应用
|
|
EP3710065B1
(en)
*
|
2017-11-13 |
2024-08-21 |
Politecnico Di Torino |
Biomimetic non-immunogenic nanoassembly for the antitumor therapy
|
|
US11661599B1
(en)
|
2017-12-14 |
2023-05-30 |
National Technology & Engineering Solutions Of Sandia, Llc |
CRISPR-Cas based system for targeting single-stranded sequences
|
|
US12383499B2
(en)
|
2018-01-01 |
2025-08-12 |
The Regents Of The University Of California |
Scale up synthesis of silicasome nanocarriers
|
|
EP3746090A4
(en)
|
2018-01-29 |
2021-11-17 |
ModernaTX, Inc. |
RSV RNA Vaccines
|
|
KR102017110B1
(ko)
*
|
2018-03-08 |
2019-09-02 |
한국화학연구원 |
구역화된 간소엽 모사체 및 이를 이용한 구역별 간독성 평가방법
|
|
CN112312918A
(zh)
*
|
2018-04-18 |
2021-02-02 |
奥依信生物技术公司 |
促融合脂质纳米粒和制备其的方法以及其用于靶细胞特异性产生治疗蛋白和治疗与靶细胞有关的疾病、病况或障碍的用途
|
|
WO2019204531A1
(en)
*
|
2018-04-18 |
2019-10-24 |
Ligandal, Inc. |
Methods and compositions for genome editing
|
|
AU2019269066B2
(en)
|
2018-05-18 |
2022-10-06 |
F. Hoffmann-La Roche Ag |
Targeted intracellular delivery of large nucleic acids
|
|
US11045554B1
(en)
|
2018-06-22 |
2021-06-29 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid-coated particles for treating viral infections
|
|
KR102316722B1
(ko)
*
|
2018-08-06 |
2021-10-26 |
주식회사 레모넥스 |
면역반응 물질 전달체
|
|
WO2020037530A1
(en)
*
|
2018-08-22 |
2020-02-27 |
Waterstone Pharmaceuticals (Wuhan) Co., Ltd. |
Crystalline form of compound and uses thereof in medicine
|
|
WO2020061295A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
CA3113025A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Peg lipids and uses thereof
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
WO2020068798A1
(en)
|
2018-09-24 |
2020-04-02 |
Guo Jimin |
Living mammalian cells modified with functional modular nanoparticles
|
|
KR20200051916A
(ko)
*
|
2018-11-05 |
2020-05-14 |
주식회사 메디포럼제약 |
고세렐린을 포함하는 실리카 하이드로겔 조성물
|
|
US20220049216A1
(en)
*
|
2018-12-24 |
2022-02-17 |
Korea University Research And Business Foundation |
Manufacture of structure capable of forming three-dimensional neuronal spheroid and generating neurite through various surface processes
|
|
IT201900001009A1
(it)
|
2019-01-23 |
2020-07-23 |
Torino Politecnico |
Vettore nanoporoso biomimetico comprendente un inibitore diretto verso la forma nativa della proteina IDH2
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
WO2020171680A1
(ko)
*
|
2019-02-22 |
2020-08-27 |
주식회사 레모넥스 |
면역활성 또는 암의 예방 또는 치료용 의약 조성물
|
|
US12208164B2
(en)
|
2019-02-28 |
2025-01-28 |
Unm Rainforest Innovations |
Modular metal-organic polyhedra superassembly compositions
|
|
US12070495B2
(en)
|
2019-03-15 |
2024-08-27 |
Modernatx, Inc. |
HIV RNA vaccines
|
|
GB201904337D0
(en)
*
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
GB201904336D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
GB201904334D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
Carrier system for preparing herbaceous extracts
|
|
EP3714879A1
(en)
|
2019-03-28 |
2020-09-30 |
Sisaf Ltd |
Structured encapsulated silicon-containing particles
|
|
WO2020200472A1
(en)
|
2019-04-05 |
2020-10-08 |
Biontech Rna Pharmaceuticals Gmbh |
Preparation and storage of liposomal rna formulations suitable for therapy
|
|
US12377118B2
(en)
*
|
2019-08-09 |
2025-08-05 |
Case Western Reserve University |
Nanoparticle constructs for systemic co-delivery of anti-tumor agents
|
|
CA3155015A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
KR20250133471A
(ko)
|
2020-02-18 |
2025-09-05 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 화합물
|
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI883391B
(zh)
|
2020-02-18 |
2025-05-11 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
MX2022011248A
(es)
|
2020-03-11 |
2022-12-15 |
Selecta Biosciences Inc |
Metodos y composiciones relacionados con nanoportadores sinteticos.
|
|
CN115348873B
(zh)
*
|
2020-03-26 |
2025-04-29 |
北京脑科学与类脑研究中心 |
氨基酸介导的基因递送及其用途
|
|
US12605395B2
(en)
|
2020-04-01 |
2026-04-21 |
University Of Cincinnati |
Materials and methods for immunosuppressive tumor microenvironment-targeted cancer therapy
|
|
US11433121B1
(en)
*
|
2020-04-03 |
2022-09-06 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid composition for the delivery of therapeutic cargos
|
|
CN113713115B
(zh)
*
|
2020-05-22 |
2023-11-24 |
青岛科技大学 |
一种采用碳多孔材料构建抗癌载药系统的方法
|
|
GB2600704A
(en)
*
|
2020-11-04 |
2022-05-11 |
Sumitomo Chemical Co |
Nanoparticle
|
|
EP4247347A4
(en)
*
|
2020-11-30 |
2024-05-22 |
Ege Universitesi |
Targeted nanoparticles carrying dual drugs in the treatment of melanoma
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
CN112870387B
(zh)
*
|
2021-02-26 |
2023-08-29 |
中山大学孙逸仙纪念医院 |
一种磁性纳米药物载体及其制备方法和应用
|
|
CN113149023B
(zh)
*
|
2021-03-11 |
2023-05-02 |
昆明理工大学 |
一种介孔二氧化硅纳米颗粒经皮递送低共熔体系制备方法
|
|
WO2022192674A1
(en)
*
|
2021-03-11 |
2022-09-15 |
The Trustees Of The University Of Pennsylvania |
Targeted therapeutic lipid nanoparticles and methods of use
|
|
CA3216162A1
(en)
|
2021-04-16 |
2022-10-20 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
|
CN113082226B
(zh)
*
|
2021-04-27 |
2023-12-15 |
山东中医药大学 |
一种载药纳米笼的制备方法与其靶向循环肿瘤细胞释放雷公藤甲素的应用
|
|
AU2022328698B2
(en)
|
2021-08-18 |
2025-02-20 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
CN113735350B
(zh)
*
|
2021-09-23 |
2023-01-24 |
深圳市水务规划设计院股份有限公司 |
一种黑臭水体处理工艺及其实验装置
|
|
JP7717252B2
(ja)
*
|
2021-10-13 |
2025-08-01 |
タンペレ・ユニバーシティー・ファウンデーション・エスアール |
細胞培養システム
|
|
CN114129718B
(zh)
*
|
2021-10-19 |
2024-05-03 |
华东师范大学 |
一种用于体内自组装car-t的纳米递送系统及其制备方法和应用
|
|
US20250327041A1
(en)
|
2022-02-24 |
2025-10-23 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
US12145890B2
(en)
|
2022-12-16 |
2024-11-19 |
Raytheon Company |
Coated (core-shell) nanoparticles for nanocomposite optical ceramics
|
|
CN116327975A
(zh)
*
|
2022-12-20 |
2023-06-27 |
中国科学院基础医学与肿瘤研究所(筹) |
一种醋酸棉酚硅脂体及其制备方法和用途
|
|
CN116327985B
(zh)
*
|
2023-02-21 |
2024-09-27 |
武汉工程大学 |
一种具有靶向超声造影成像功能的空心囊泡载药递送系统及其制备方法与应用
|
|
KR102736072B1
(ko)
*
|
2023-05-15 |
2024-12-05 |
주식회사 엠피오스 |
소수성 약물의 서방출용 실리카 기반 나노입자, 이의 제조방법 및 이를 포함하는 경피 약물투여시스템
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|